Used as a key intermediate in the synthesis of kinase inhibitors, particularly in the development of targeted cancer therapies. Its structure enables selective binding to specific enzyme active sites, making it valuable in pharmaceutical research for designing drugs that modulate cell signaling pathways. Commonly employed in Suzuki and Negishi coupling reactions to build complex heterocyclic systems found in bioactive molecules. Also utilized in the preparation of small-molecule inhibitors for inflammatory and neurodegenerative diseases due to its favorable binding properties with ATP-binding pockets in kinases.